Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
527 hedge funds and large institutions have $12B invested in Exact Sciences in 2019 Q4 according to their latest regulatory filings, with 128 funds opening new positions, 199 increasing their positions, 128 reducing their positions, and 64 closing their positions.
100% more first-time investments, than exits
New positions opened: 128 | Existing positions closed: 64
86% more funds holding in top 10
Funds holding in top 10: 7 → 13 (+6)
55% more repeat investments, than reductions
Existing positions increased: 199 | Existing positions reduced: 128
17% more capital invested
Capital invested by funds: $10.3B → $12B (+$1.76B)
11% more funds holding
Funds holding: 475 → 527 (+52)
0.64% more ownership
Funds ownership: 87.9% → 88.54% (+0.64%)
43% less call options, than puts
Call options by funds: $317M | Put options by funds: $561M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$622M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$227M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$138M |
| 4 |
CG
Carmignac Gestion
Paris,
France
|
+$76.8M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$68.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$167M |
| 2 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$96M |
| 3 |
FAM
Fred Alger Management
New York
|
-$54.9M |
| 4 |
D.E. Shaw & Co
New York
|
-$50.3M |
| 5 |
Renaissance Technologies
New York
|
-$47M |
EXAS Hedge Fund Activity: Q4 2019 in Review
527 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q4 2019, worth a combined $12B — up 17% from $10.3B a quarter earlier.
Buyers outnumbered sellers: 128 funds opened new EXAS positions and 64 closed out — a net gain of 64 holders — while 199 added to existing stakes and 128 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $622M. The largest seller was Wellington Management Group, cutting an estimated $167M.
- 527 institutional investors held Exact Sciences (EXAS) as of Q4 2019, up from 475 in Q3 2019.
- Funds reported $12B of Exact Sciences stock for Q4 2019, up 17% quarter-over-quarter.
- 128 funds opened new Exact Sciences positions in Q4 2019 and 64 closed out, a net change of +64 holders.
- The largest Exact Sciences buyer in Q4 2019 was T. Rowe Price Associates, an estimated $622M added.
- The largest Exact Sciences seller in Q4 2019 was Wellington Management Group, an estimated $167M sold.
Based on aggregated 13F filings for Q4 2019.